Last updated on March 2019

Starter Kit Study in Insulin na ve Patients


Brief description of study

The concept consists of an initial period (two weeks) of intensive data capture by use of continuous glucose monitoring (CGM) during basal insulin initiation, followed by a second period (variable duration) of basal insulin titration guided by self monitored blood glucose. Data captured during the first period are used as input to an algorithm that estimates the optimal daily dose for the individual patient. The estimated optimal daily dose is used to guide the titration of the basal insulin during the second period. The goal is to safely and successfully achieve blood glucose targets. The concept is based on the use of basal insulin degludec (Tresiba, Novo Nordisk A/S).

Clinical Study Identifier: NCT03365180

Find a site near you

Start Over

Hvidovre University Hospital

Hvidovre, Denmark
3.93miles
  Connect »